Print

AMAG Pharmaceuticals, Inc. (AMAG) Investor MSMB Makes $378 Million Takeover Bid for Firm to Stop Merger With Allos Therapeutics, Inc. (ALTH)  
8/3/2011 9:38:56 AM

MSMB Capital Management, a New York- based hedge fund, made an unsolicited, $378 million takeover bid for Amag Pharmaceuticals Inc. (AMAG) and said it will fire the drugmaker’s top management if successful.
//-->